Join EvoPharma

Apply to become a builder.

EvoPharma is open to global contributors who can complete assigned responsibilities and create verified company value.

No free ownership.

Applying, meeting, advising, promising, or making introductions does not create ownership. Ownership is considered only after assigned responsibility is completed, documented, verified, and accepted.

0%Before completion
100%Responsibility-based

Who can apply?

EvoPharma welcomes scientists, AI researchers, medicinal chemists, clinicians, CRO experts, operators, investors, advisors, legal/IP professionals, business-development contributors, marketing builders, and strategic partners.

Scientific and technical builders

Therapeutic strategy, computational design, docking, synthesis planning, enzymatic IC50, in-vitro validation, and in-vivo execution.

Execution and company builders

Outsourced experiment management, CRO/vendor coordination, IP protection, financing readiness, investor materials, and operations.

Strategic builders

External collaborations, pharma BD, marketing, visibility, future development, investor networks, and long-term company growth.

Responsibility-completion rule

No completed responsibility, no ownership.

Applicants are not owners. Contributors are not owners. Advisors are not owners. A person becomes eligible for ownership only after a written responsibility is completed, documented, verified, accepted, and formally approved.

Outsourced execution model

EvoPharma may outsource experiments, synthesis, assays, validation, legal work, and operational tasks. But EvoPharma does not outsource responsibility.

Builders must make outsourced execution happen: define the work, identify qualified partners, manage scope, verify output, solve failures, and integrate results into company progress.

Automated application form

Builder Application

Use this form to show your interest in joining EvoPharma. Submissions are automatically sent to EvoPharma for preliminary screening.

Important: Submission does not create ownership, employment, advisory status, authority, confidentiality access, governance rights, or any right to represent EvoPharma.

Delivery: Completed applications are sent directly to EvoPharma by email.
1. Applicant Information
2. Contribution Pathway
3. Conflicts, Confidentiality, and IP
4. Preliminary NDA and Application Agreement

Preliminary Confidentiality / NDA Terms

By submitting this application, you agree that any non-public information EvoPharma shares with you during the application or screening process is confidential and may be used only for evaluating a possible contribution to EvoPharma.

You agree not to copy, disclose, publish, distribute, reverse engineer, use, or exploit EvoPharma confidential information, scientific concepts, compound ideas, business plans, investor materials, collaborator information, IP strategy, data, documents, or internal communications for any personal, academic, commercial, employer, client, or third-party purpose without written permission from EvoPharma.

You acknowledge that applying does not make you an owner, employee, advisor, officer, partner, agent, representative, or authorized person of EvoPharma. You may not contact investors, CROs, partners, collaborators, vendors, media, or third parties on behalf of EvoPharma unless EvoPharma authorizes you in writing.

You agree that any work product, invention, analysis, design, document, code, data, workflow, report, protocol, figure, or other material created specifically for EvoPharma after acceptance into a contributor pathway may require formal IP assignment to EvoPharma before ownership consideration.

This online acknowledgment supports preliminary screening. EvoPharma may require a separate formal NDA, IP assignment, contributor agreement, and legal review before sharing confidential information or assigning responsibilities.

After submission, selected applicants may be contacted for screening. Ownership consideration occurs only after completed responsibility creates verified company value.